Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 8
1964 5
1965 3
1966 3
1967 5
1968 6
1969 13
1970 10
1971 13
1972 16
1973 18
1974 21
1975 13
1976 15
1977 14
1978 4
1979 18
1980 24
1981 20
1982 25
1983 29
1984 26
1985 24
1986 17
1987 46
1988 28
1989 51
1990 51
1991 62
1992 60
1993 69
1994 70
1995 44
1996 63
1997 80
1998 111
1999 63
2000 97
2001 92
2002 103
2003 127
2004 110
2005 126
2006 117
2007 130
2008 129
2009 171
2010 126
2011 111
2012 152
2013 134
2014 158
2015 141
2016 144
2017 155
2018 158
2019 159
2020 160
2021 174
2022 178
2023 165
2024 51

Text availability

Article attribute

Article type

Publication date

Search Results

4,181 results

Results by year

Filters applied: . Clear all
Page 1
Renal Thrombotic Microangiopathy: A Review.
Genest DS, Patriquin CJ, Licht C, John R, Reich HN. Genest DS, et al. Am J Kidney Dis. 2023 May;81(5):591-605. doi: 10.1053/j.ajkd.2022.10.014. Epub 2022 Dec 10. Am J Kidney Dis. 2023. PMID: 36509342 Review.
Thrombotic microangiopathy (TMA), a pathological lesion observed in a wide spectrum of diseases, is triggered by endothelial injury and/or dysfunction. ...Major advances have been made with respect to the pathophysiology of primary TMA entities, with the subsequent
Thrombotic microangiopathy (TMA), a pathological lesion observed in a wide spectrum of diseases, is triggered by endothelial i
Thrombotic Microangiopathy and the Kidney.
Brocklebank V, Wood KM, Kavanagh D. Brocklebank V, et al. Clin J Am Soc Nephrol. 2018 Feb 7;13(2):300-317. doi: 10.2215/CJN.00620117. Epub 2017 Oct 17. Clin J Am Soc Nephrol. 2018. PMID: 29042465 Free PMC article. Review.
Thrombotic microangiopathy can manifest in a diverse range of diseases and is characterized by thrombocytopenia, microangiopathic hemolytic anemia, and organ injury, including AKI. ...This review considers the classification, pathology, epidemiology, characteristics
Thrombotic microangiopathy can manifest in a diverse range of diseases and is characterized by thrombocytopenia, microangiopat
Diagnosis and treatment of thrombotic microangiopathy.
Thompson GL, Kavanagh D. Thompson GL, et al. Int J Lab Hematol. 2022 Sep;44 Suppl 1(Suppl 1):101-113. doi: 10.1111/ijlh.13954. Int J Lab Hematol. 2022. PMID: 36074708 Free PMC article. Review.
Thrombotic microangiopathy (TMA) is characterized by thrombocytopenia, microangiopathic haemolytic anaemia and end organ damage. ...
Thrombotic microangiopathy (TMA) is characterized by thrombocytopenia, microangiopathic haemolytic anaemia and end organ damag
Syndromes of thrombotic microangiopathy.
George JN, Nester CM. George JN, et al. N Engl J Med. 2014 Aug 14;371(7):654-66. doi: 10.1056/NEJMra1312353. N Engl J Med. 2014. PMID: 25119611 Free article. Review.
Atypical Hemolytic-Uremic Syndrome: An Update on Pathophysiology, Diagnosis, and Treatment.
Raina R, Krishnappa V, Blaha T, Kann T, Hein W, Burke L, Bagga A. Raina R, et al. Ther Apher Dial. 2019 Feb;23(1):4-21. doi: 10.1111/1744-9987.12763. Epub 2018 Oct 29. Ther Apher Dial. 2019. PMID: 30294946 Review.
Atypical hemolytic uremic syndrome (aHUS), a rare variant of thrombotic microangiopathy, is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and renal impairment. ...
Atypical hemolytic uremic syndrome (aHUS), a rare variant of thrombotic microangiopathy, is characterized by microangiopathic …
Thrombotic microangiopathy in children.
Palma LMP, Vaisbich-Guimarães MH, Sridharan M, Tran CL, Sethi S. Palma LMP, et al. Pediatr Nephrol. 2022 Sep;37(9):1967-1980. doi: 10.1007/s00467-021-05370-8. Epub 2022 Jan 18. Pediatr Nephrol. 2022. PMID: 35041041 Free PMC article. Review.
The syndrome of thrombotic microangiopathy (TMA) is a clinical-pathological entity characterized by microangiopathic hemolytic anemia, thrombocytopenia, and end organ involvement. ...
The syndrome of thrombotic microangiopathy (TMA) is a clinical-pathological entity characterized by microangiopathic hemolytic …
An update on pathogenesis and diagnosis of thrombotic thrombocytopenic purpura.
Joly BS, Coppo P, Veyradier A. Joly BS, et al. Expert Rev Hematol. 2019 Jun;12(6):383-395. doi: 10.1080/17474086.2019.1611423. Epub 2019 May 20. Expert Rev Hematol. 2019. PMID: 31107120 Review.
Introduction: Thrombotic thrombocytopenic purpura (TTP) is a rare and life-threatening thrombotic microangiopathy characterized by microangiopathic hemolytic anemia, consumption thrombocytopenia, and organ injury. ...
Introduction: Thrombotic thrombocytopenic purpura (TTP) is a rare and life-threatening thrombotic microangiopathy chara …
Haemolytic uraemic syndrome.
Michael M, Bagga A, Sartain SE, Smith RJH. Michael M, et al. Lancet. 2022 Nov 12;400(10364):1722-1740. doi: 10.1016/S0140-6736(22)01202-8. Epub 2022 Oct 19. Lancet. 2022. PMID: 36272423 Review.
Haemolytic uraemic syndrome (HUS) is a heterogeneous group of diseases that result in a common pathology, thrombotic microangiopathy, which is classically characterised by the triad of non-immune microangiopathic haemolytic anaemia, thrombocytopenia, and acute kidne …
Haemolytic uraemic syndrome (HUS) is a heterogeneous group of diseases that result in a common pathology, thrombotic microangiopat
Thrombotic Microangiopathy Syndromes-Common Ground and Distinct Frontiers.
Hanna RM, Henriksen K, Kalantar-Zadeh K, Ferrey A, Burwick R, Jhaveri KD. Hanna RM, et al. Adv Chronic Kidney Dis. 2022 Mar;29(2):149-160.e1. doi: 10.1053/j.ackd.2021.11.006. Adv Chronic Kidney Dis. 2022. PMID: 35817522 Review.
Thrombotic microangiopathies (TMAs) have in common a terminal phenotype of microangiopathic hemolytic anemia with end-organ dysfunction. Thrombotic thrombocytopenic purpura results from von Willebrand factor multimerization, Shiga toxin-mediated hemolytic ure
Thrombotic microangiopathies (TMAs) have in common a terminal phenotype of microangiopathic hemolytic anemia with end-organ dy
Hemolytic-Uremic Syndrome in Children.
Boyer O, Niaudet P. Boyer O, et al. Pediatr Clin North Am. 2022 Dec;69(6):1181-1197. doi: 10.1016/j.pcl.2022.07.006. Epub 2022 Oct 29. Pediatr Clin North Am. 2022. PMID: 36880929 Review.
4,181 results